Skip to main content
. 2018 Jul 31;163(11):3023–3033. doi: 10.1007/s00705-018-3966-8

Fig. 4.

Fig. 4

Multiple cellular factors and signaling events were involved in STIV entry. (A, C) Determination of the fluorescence intensity of EGFP-STIV-infected cells after treatment with DMSO, cyto-D, dynasore, genistein or ML-7. (B, D) Percentage of EGFP-STIV-infected cells after treatment with DMSO, cyto-D, dynasore, genistein or ML-7 by flow cytometry. (E) Western blotting detection of protein synthesis of the STIV major capsid protein after treatment with dynasore or ML-7